000154696 001__ 154696
000154696 005__ 20240229123109.0
000154696 0247_ $$2doi$$a10.1002/mds.28039
000154696 0247_ $$2pmid$$apmid:32357270
000154696 0247_ $$2ISSN$$a0885-3185
000154696 0247_ $$2ISSN$$a1531-8257
000154696 0247_ $$2altmetric$$aaltmetric:81186441
000154696 037__ $$aDKFZ-2020-00954
000154696 041__ $$aeng
000154696 082__ $$a610
000154696 1001_ $$00000-0001-5662-1971$$aPeters, Susan$$b0
000154696 245__ $$aAlcohol Consumption and Risk of Parkinson's Disease: Data from a Large Prospective European Cohort.
000154696 260__ $$aNew York, NY$$bWiley$$c2020
000154696 3367_ $$2DRIVER$$aarticle
000154696 3367_ $$2DataCite$$aOutput Types/Journal article
000154696 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1598872457_21558
000154696 3367_ $$2BibTeX$$aARTICLE
000154696 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000154696 3367_ $$00$$2EndNote$$aJournal Article
000154696 500__ $$a2020 Jul;35(7):1258-1263
000154696 520__ $$aParkinson's disease (PD) etiology is not well understood. Reported inverse associations with smoking and coffee consumption prompted the investigation of alcohol consumption as a risk factor, for which evidence is inconclusive.To assess the associations between alcohol consumption and PD risk.Within NeuroEPIC4PD, a prospective European population-based cohort, 694 incident PD cases were ascertained from 209,998 PD-free participants. Average alcohol consumption at different time points was self-reported at recruitment. Cox regression hazard ratios were estimated for alcohol consumption and PD occurrence.No associations between baseline or lifetime total alcohol consumption and PD risk were observed. Men with moderate lifetime consumption (5-29.9 g/day) were at ~50% higher risk compared with light consumption (0.1-4.9 g/day), but no linear exposure-response trend was observed. Analyses by beverage type also revealed no associations with PD.Our data reinforce previous findings from prospective studies showing no association between alcohol consumption and PD risk. © 2020 The Authors. Movement Disorders published by Wiley Periodicals, Inc. on behalf of International Parkinson and Movement Disorder Society.
000154696 536__ $$0G:(DE-HGF)POF3-313$$a313 - Cancer risk factors and prevention (POF3-313)$$cPOF3-313$$fPOF III$$x0
000154696 588__ $$aDataset connected to CrossRef, PubMed,
000154696 7001_ $$00000-0002-1268-8629$$aGallo, Valentina$$b1
000154696 7001_ $$aVineis, Paolo$$b2
000154696 7001_ $$aMiddleton, Lefkos T$$b3
000154696 7001_ $$aForsgren, Lars$$b4
000154696 7001_ $$aSacerdote, Carlotta$$b5
000154696 7001_ $$aSieri, Sabina$$b6
000154696 7001_ $$aKyrozis, Andreas$$b7
000154696 7001_ $$aChirlaque, María-Dolores$$b8
000154696 7001_ $$aZamora-Ros, Raul$$b9
000154696 7001_ $$aHansson, Oskar$$b10
000154696 7001_ $$aPetersson, Jesper$$b11
000154696 7001_ $$0P:(DE-He78)fb68a9386399d72d84f7f34cfc6048b4$$aKatzke, Verena$$b12$$udkfz
000154696 7001_ $$0P:(DE-He78)0907a10ba1dc8f53f04907f54f6fdcfe$$aKühn, Tilman$$b13$$udkfz
000154696 7001_ $$aMokoroa, Olatz$$b14
000154696 7001_ $$aMasala, Giovanna$$b15
000154696 7001_ $$aArdanaz, Eva$$b16
000154696 7001_ $$aPanico, Salvatore$$b17
000154696 7001_ $$aBergmann, Manuela M$$b18
000154696 7001_ $$aKey, Timothy J$$b19
000154696 7001_ $$aWeiderpass, Elisabete$$b20
000154696 7001_ $$aFerrari, Pietro$$b21
000154696 7001_ $$aVermeulen, Roel$$b22
000154696 773__ $$0PERI:(DE-600)2041249-6$$a10.1002/mds.28039$$gp. mds.28039$$n7$$p1258-1263$$tMovement disorders$$v35$$x1531-8257$$y2020
000154696 909CO $$ooai:inrepo02.dkfz.de:154696$$pVDB
000154696 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)fb68a9386399d72d84f7f34cfc6048b4$$aDeutsches Krebsforschungszentrum$$b12$$kDKFZ
000154696 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)0907a10ba1dc8f53f04907f54f6fdcfe$$aDeutsches Krebsforschungszentrum$$b13$$kDKFZ
000154696 9131_ $$0G:(DE-HGF)POF3-313$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vCancer risk factors and prevention$$x0
000154696 9141_ $$y2020
000154696 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz
000154696 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bMOVEMENT DISORD : 2017
000154696 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000154696 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000154696 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000154696 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List
000154696 915__ $$0StatID:(DE-HGF)0110$$2StatID$$aWoS$$bScience Citation Index
000154696 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000154696 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000154696 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine
000154696 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences
000154696 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bMOVEMENT DISORD : 2017
000154696 9201_ $$0I:(DE-He78)C020-20160331$$kC020$$lC020 Epidemiologie von Krebs$$x0
000154696 980__ $$ajournal
000154696 980__ $$aVDB
000154696 980__ $$aI:(DE-He78)C020-20160331
000154696 980__ $$aUNRESTRICTED